ArticleWorld journal of clinical oncology2023

Clinical outcomes of newly diagnosed primary central nervous system lymphoma treated with zanubrutinib-based combination therapy.

Ning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.